Health and Healthcare
How Ebola Stocks Are Responding After the Outbreak in the Congo
Published:
Last Updated:
The World Health Organization (WHO) has confirmed a new outbreak of the Ebola virus in the Democratic Republic of Congo. So far at least one person has died after contracting the virus, in a lab-confirmed case. This is the first time in a while that the virus has resurfaced, and a few of the Ebola-related stocks are responding.
In the last major outbreak between 2014 and 2015, over 11,000 people died in West Africa, mainly in Guinea, Sierra Leone and Liberia.
24/7 Wall St. has taken a quick look at a few stocks that have an Ebola treatment in their portfolio or deal directly with the virus. We have included a recent trading history, as well as some color and the consensus analyst price target.
Sarepta Therapeutics Inc. (NASDAQ: SRPT) saw its shares up 1.5% at $34.02, with a consensus analyst price target of $60.88 and a 52-week trading range of $14.83 to $63.73. Year to date, shares are up 22%.
Lakeland Industries Inc. (NASDAQ: LAKE) shares are up over 8% at $11.94. The stock has a 52-week range of $8.00 to $11.95 and a consensus price target of $15.00. So far in 2017, excluding Friday’s move, the stock is up nearly 6%.
Novavax Inc. (NASDAQ: NVAX) shares are up 1% at $0.94, with a consensus price target of $3.48 and a 52-week range of $0.73 to $8.49. Year to date, the stock is down 26%.
NewLink Genetics Corp. (NASDAQ: NLNK) saw its stock jump 3.6% to $17.45, within a 52-week range of $9.41 to $25.17 and with a consensus price target of $26.80. In 2017, the stock is up 63%.
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) shares are up nearly 1% at $90.16. The stock has a 52-week range of $73.45 to $102.49. Year to date, the stock is up about 8%.
Essential Tips for Investing: Sponsored
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
